SOPHiA GENETICS S.A. (SOPH)
$7.09-1.80%Close
SELLCRISIS · day 6
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $494M
- Beta
- 0.95
- P/E (TTM)
- -6.17
- Short % float
- 1.87%
- Days to cover
- 1.7
- SI change
- +4.8%
- 1W
- -3.93%
- 1M
- -9.80%
- vs SPY 1W
- -3.79%
- vs SPY 1M
- -12.30%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 7
- VALUE
- 8
- GROWTH
- 28
- GARP
- 6
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-82.0%
REV YoY-
ROE-136.7%
EPS YoY-
ROA-40.8%
GROSS67
OP-85
NET-94
[VALUATION]
P/E TTM-6.17
P/E FWD-
SECTOR PE20.34
INDUSTRY PE24.21
P/B6.30
P/FCF-
EV/EBITDA-8.61
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E74.38
ALTMAN Z-
CURR RATIO2.69
ND/EBITDA-
BETA0.95
Company news
FAQ
- What is LOPJLB’s current signal on SOPH?
- LOPJLB’s latest quantitative signal on SOPHiA GENETICS S.A. (SOPH) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is SOPH in?
- SOPHiA GENETICS S.A. (SOPH) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does SOPHiA GENETICS S.A. (SOPH) do?
- SOPHiA GENETICS S.A. operates as a specialized company within the healthcare technology sector. The firm provides the SOPHiA DDM platform, a cloud-native Software-as-a-Service (SaaS) solution engineered to analyze diverse multimodal datasets and various diagnostic inputs, thereby extracting valuable insights. This platform, together with its related offerings and services, is widely adopted by …